1. Home
  2. ARAY vs OVID Comparison

ARAY vs OVID Comparison

Compare ARAY & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

N/A

Current Price

$0.41

Market Cap

68.6M

Sector

Health Care

ML Signal

N/A

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

N/A

Current Price

$2.00

Market Cap

117.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARAY
OVID
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.6M
117.5M
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
ARAY
OVID
Price
$0.41
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$3.50
$3.40
AVG Volume (30 Days)
887.9K
1.5M
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
87.50
3.90
EPS
N/A
N/A
Revenue
N/A
$566,000.00
Revenue This Year
N/A
$1,077.56
Revenue Next Year
$4.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.24
52 Week High
$2.10
$2.38

Technical Indicators

Market Signals
Indicator
ARAY
OVID
Relative Strength Index (RSI) 22.29 67.31
Support Level N/A $1.43
Resistance Level $0.63 $2.01
Average True Range (ATR) 0.04 0.15
MACD -0.00 0.05
Stochastic Oscillator 0.00 60.11

Price Performance

Historical Comparison
ARAY
OVID

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: